Access cutting-edge cystic fibrosis treatment through this clinical trial at a research site in Orlando. Study-provided care at no cost to qualified participants.
Access cystic fibrosis specialists in Orlando at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cystic fibrosis treatment provided free
ARCT-032-02 is a Phase 2, open-label, multicenter, multiple-ascending dose study of ARCT-032 in adults with CF who are not eligible for CFTR modulator therapy or are not taking CFTR modulators due to drug intolerance, poor response, or lack of access to modulators.
Sponsor: Arcturus Therapeutics, Inc.
Check if you qualify for this cystic fibrosis clinical trial in Orlando, FL
If you're searching for cystic fibrosis treatment options in Orlando, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Orlando research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cystic fibrosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.